RIP XTuit: Great brains, hot target and vet CEO Deborah Dunsire in charge couldn’t stop this biotech from going down
The biotech news these days is dominated by startups and big money, but the cautionary tales still keep coming.
XTuit Pharmaceuticals had banked on the ideas of some of the most prominent scientists engaged in drug development, relied on a seasoned biotech exec as CEO and had solid backing from some marquee investors like Polaris and NEA.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.